Profil
Michael E.
Markels worked as a Senior Director in Marketing at Biogen, Inc. in 2006.
He also worked as a Senior Director in Infectious Disease & Oncology at InterMune, Inc. in 2002.
From 1990 to 2001, he worked at Glaxo Wellcome, Inc. as a Director in Global Commercial Strategy.
He was also a Senior VP in Commercial & Business Development at NeurogesX, Inc. Mr. Markels holds an MBA from Duke University and an undergraduate degree from Colorado State University.
Anciens postes connus de Michael E. Markels
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Sales & Marketing | 01/05/2006 |
| INTERMUNE INC | Corporate Officer/Principal | 01/10/2002 |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Corporate Officer/Principal | 01/01/2001 |
| NEUROGESX, INC | Corporate Officer/Principal | - |
Formation de Michael E. Markels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeurogesX, Inc.
NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pain management therapies | Health Technology |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
















